Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.9900
-0.0300 (-2.94%)
At close: Sep 18, 2025, 4:00 PM EDT
1.010
+0.020 (2.02%)
After-hours: Sep 18, 2025, 7:59 PM EDT
Outlook Therapeutics Market Cap
Outlook Therapeutics has a market cap or net worth of $43.98 million as of September 18, 2025. Its market cap has decreased by -74.71% in one year.
Market Cap
43.98M
Enterprise Value
69.77M
1-Year Change
-74.71%
Ranking
Category
Stock Price
$0.99
Market Cap Chart
Since June 14, 2016, Outlook Therapeutics's market cap has decreased from $97.37M to $43.98M, a decrease of -54.84%. That is a compound annual growth rate of -8.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 45.31M | -3.75% |
| Dec 31, 2024 | 47.07M | -54.10% |
| Dec 29, 2023 | 102.54M | -63.01% |
| Dec 30, 2022 | 277.20M | -9.11% |
| Dec 31, 2021 | 304.99M | 84.47% |
| Dec 31, 2020 | 165.34M | 630.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 14, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.91B |
| Johnson & Johnson | 419.44B |
| AbbVie | 392.16B |
| UnitedHealth Group | 303.24B |
| Novo Nordisk | 275.39B |
| AstraZeneca | 236.44B |
| Novartis AG | 236.39B |
| Abbott Laboratories | 234.21B |